Literature DB >> 32114264

Automated delineation of the clinical target volume using anatomically constrained 3D expansion of the gross tumor volume.

Nadya Shusharina1, Jonas Söderberg2, David Edmunds1, Fredrik Löfman2, Helen Shih3, Thomas Bortfeld4.   

Abstract

PURPOSE: Delineation of the clinical target volume (CTV) is arguably the weakest link in the treatment planning chain. This work aims to support clinicians in this crucial task. METHODS AND MATERIALS: While the CTV itself is ambiguous, it is much easier to identify structures that do not belong to the CTV and serve as barriers to the spread of the disease. We segment the known barrier structures using a convolutional neural network (CNN). The CTV is then obtained by starting from the manually delineated gross tumor volume (GTV) and expanding it while taking into account the barrier structures. Mathematically, we define the CTV as an iso-surface in the 3D map of shortest paths of all voxels from the GTV. The shortest paths are found with the Dijkstra algorithm. While the method is generally applicable, we test it on 206 glioma and glioblastoma cases.
RESULTS: The auto-segmented barrier structures for the brain cases include the ventricles, falx cerebri, tentorium cerebelli, brain sinuses, and the outer surface of the brain. Manual and auto-segmented barrier structures agree with surface Dice Similarity Coefficients (DSC) ranging from 0.91 to 0.97 at 2 mm tolerance. Comparison of manual and automatically delineated CTVs shows a median surface DSC of 0.79.
CONCLUSIONS: Barrier structures for CTV definition can be auto-delineated with outstanding precision using a CNN. An algorithm for automated calculation of the CTV by 3D expansion of the GTV while respecting anatomical barriers has been developed. It shows good agreement with manual CTV definition for brain tumors.
Copyright © 2020 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  3D expansion; Anatomical barriers; Clinical target volume; Dijkstra algorithm; Glioma; Machine learning

Mesh:

Year:  2020        PMID: 32114264     DOI: 10.1016/j.radonc.2020.01.028

Source DB:  PubMed          Journal:  Radiother Oncol        ISSN: 0167-8140            Impact factor:   6.280


  7 in total

1.  Modeling the propagation of tumor fronts with shortest path and diffusion models-implications for the definition of the clinical target volume.

Authors:  Thomas Bortfeld; Gregory Buti
Journal:  Phys Med Biol       Date:  2022-07-25       Impact factor: 4.174

2.  Automated clinical target volume delineation using deep 3D neural networks in radiation therapy of Non-small Cell Lung Cancer.

Authors:  Yunhe Xie; Kongbin Kang; Yi Wang; Melin J Khandekar; Henning Willers; Florence K Keane; Thomas R Bortfeld
Journal:  Phys Imaging Radiat Oncol       Date:  2021-08-23

3.  Evaluation of a Dedicated Software "Elements™ Spine SRS, Brainlab®" for Target Volume Definition in the Treatment of Spinal Bone Metastases With Stereotactic Body Radiotherapy.

Authors:  Maximilien Rogé; Ahmed Hadj Henni; Yasmine Adda Neggaz; Romain Mallet; Chantal Hanzen; Bernard Dubray; Elyse Colard; David Gensanne; Sébastien Thureau
Journal:  Front Oncol       Date:  2022-05-12       Impact factor: 5.738

4.  CTV Delineation for High-Grade Gliomas: Is There Agreement With Tumor Cell Invasion Models?

Authors:  Wille Häger; Marta Lazzeroni; Mehdi Astaraki; Iuliana Toma-Daşu
Journal:  Adv Radiat Oncol       Date:  2022-05-05

5.  Method of computing direction-dependent margins for the development of consensus contouring guidelines.

Authors:  Liam S P Lawrence; Lee C L Chin; Rachel W Chan; Timothy K Nguyen; Arjun Sahgal; Chia-Lin Tseng; Angus Z Lau
Journal:  Radiat Oncol       Date:  2021-04-13       Impact factor: 3.481

6.  An Adversarial Deep-Learning-Based Model for Cervical Cancer CTV Segmentation With Multicenter Blinded Randomized Controlled Validation.

Authors:  Zhikai Liu; Wanqi Chen; Hui Guan; Hongnan Zhen; Jing Shen; Xia Liu; An Liu; Richard Li; Jianhao Geng; Jing You; Weihu Wang; Zhouyu Li; Yongfeng Zhang; Yuanyuan Chen; Junjie Du; Qi Chen; Yu Chen; Shaobin Wang; Fuquan Zhang; Jie Qiu
Journal:  Front Oncol       Date:  2021-08-19       Impact factor: 6.244

Review 7.  Molecular Biology in Treatment Decision Processes-Neuro-Oncology Edition.

Authors:  Andra V Krauze; Kevin Camphausen
Journal:  Int J Mol Sci       Date:  2021-12-10       Impact factor: 5.923

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.